Product image of Niklod (Clodronate Disodium, Lidocaine Hydrochloride) supplied by GNH India

Niklod

Active Ingredient:
Clodronate Disodium, Lidocaine Hydrochloride
Origin:
EU

Niklod (Clodronate Disodium, Lidocaine Hydrochloride)

Clodronate Disodium, the active ingredient in Niklod, is a bisphosphonate presented as an injectable formulation for intramuscular use. Combined with Lidocaine Hydrochloride, a local anesthetic, the product is employed to alleviate bone‑related pain, manage hypercalcemia of malignancy, and provide local anesthesia during intramuscular procedures.

GNH India supplies Niklod as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide, ensuring quality‑controlled manufacturing and regulatory compliance for global distribution.

Manufacturer / TM Owner

I.B.N. Savio S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Niklod is used in the management of bone‑related conditions and for procedural anesthesia.

  • Bone metastases pain: reduces skeletal pain associated with metastatic disease.
  • Hypercalcemia of malignancy: lowers elevated serum calcium levels in cancer patients.
  • Intramuscular local anesthesia: provides rapid numbness at the injection site for procedures.

How It Works

  • Clodronate disodium binds to hydroxyapatite crystals in bone, where it is internalized by osteoclasts and triggers apoptosis, thereby decreasing bone resorption. Lidocaine hydrochloride blocks voltage‑gated sodium channels on neuronal membranes, preventing depolarization and producing a reversible loss of sensation at the injection site. The combined actions result in analgesia from both reduced bone turnover and local nerve blockade.

Side Effects

Adverse reactions to Niklod may range from mild to severe.

Common Side Effects

  • Injection site pain
  • Redness or swelling at the site
  • Mild nausea
  • Transient dizziness
  • Local irritation or itching
  • Low‑grade fever

Serious or Rare Side Effects

  • Severe hypocalcemia
  • Osteonecrosis of the jaw
  • Anaphylactic reaction
  • Cardiac arrhythmias
  • Acute renal impairment
  • Stevens‑Johnson syndrome or toxic epidermal necrolysis

Precautions & Warnings

Before prescribing Niklod, clinicians should consider the following precautions.

  • Renal function: assess baseline kidney function and monitor during therapy.
  • Serum calcium: measure calcium levels before initiation and periodically thereafter.
  • Pregnancy: safety not established; avoid use unless benefits outweigh risks.
  • Lidocaine allergy: contraindicated in patients with known hypersensitivity to local anesthetics.
  • Concomitant bisphosphonates: avoid duplicate therapy to reduce risk of oversuppression of bone turnover.
  • Store at ambient temperature: keep in original packaging, protect from moisture and light.

Avoid Interactions

Niklod can interact with other medicines; notable interactions are classified as follows.

Major Interactions (Avoid)

  • Concurrent bisphosphonates: may cause excessive inhibition of bone resorption.
  • Nephrotoxic agents (e.g., aminoglycosides, amphotericin B): increase risk of renal injury.
  • High‑dose calcium supplements: reduce clodronate absorption and efficacy.
  • NSAIDs: potentiate renal toxicity when combined with clodronate.
  • Strong CYP450 inhibitors: may elevate lidocaine plasma levels, increasing toxicity risk.

Moderate Interactions (Monitor Closely)

  • Antacids containing aluminum or magnesium: may impair clodronate uptake.
  • Loop diuretics: alter calcium balance, requiring monitoring.
  • Warfarin: monitor INR as clodronate may affect coagulation.
  • Other local anesthetics: cumulative systemic toxicity risk.
  • Corticosteroids: may increase risk of osteonecrosis of the jaw.

Frequently Asked Questions

Niklod is an injectable medication that combines clodronate disodium, a bisphosphonate, with lidocaine hydrochloride, a local anesthetic. It is indicated for relieving pain caused by bone metastases, treating hypercalcemia of malignancy, and providing local anesthesia for intramuscular procedures.

Clodronate disodium binds to bone mineral surfaces and is taken up by osteoclasts, where it induces apoptosis. This reduces osteoclast‑mediated bone resorption, helping to stabilize bone and lower calcium release, which alleviates skeletal pain and hypercalcemia.

The dose of Niklod is determined by the prescribing clinician based on the patient’s specific condition, weight, renal function, and response to therapy. No fixed regimen is provided here; the healthcare professional will set the appropriate dosing schedule.

Safety data for Niklod in pregnancy and lactation are limited. It is generally advised to avoid use unless the potential benefit justifies the potential risk to the fetus or infant. Clinicians should discuss individual risk factors with the patient.

To order Niklod, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and import documentation.

Niklod combines a bisphosphonate (clodronate) with a local anesthetic, offering both bone‑protective effects and immediate analgesia at the injection site. Unlike some other bisphosphonates that lack anesthetic properties, Niklod can reduce procedural discomfort while managing bone‑related pain and hypercalcemia.

Niklod should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the vials from moisture and direct light. Do not freeze the product, and handle it according to standard aseptic techniques for injectable medicines.

Niklod is administered by a qualified healthcare professional as an intramuscular injection. The injection site is prepared aseptically, and the dose is delivered slowly to minimize local irritation. The lidocaine component provides immediate numbness, while the clodronate component acts systemically.

Serious risks include severe hypocalcemia, osteonecrosis of the jaw, anaphylactic reactions, cardiac arrhythmias, acute renal impairment, and rare severe skin reactions such as Stevens‑Johnson syndrome. Patients should be monitored closely for these events, especially during the initial treatment period.

Niklod is contraindicated in patients with known hypersensitivity to clodronate, lidocaine, or any excipients in the formulation. It should also be avoided in individuals with severe renal impairment, uncontrolled electrolyte abnormalities, or those currently receiving other bisphosphonate therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Clodronate Disodium, Lidocaine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT